BioSpace News Archive

Pharm Country

MYOS to Introduce its Longevity Business with its Physician Muscle Health Formula at the World Congress on Anti-Aging Medicine in Las Vegas December 13-15, 2019

MYOS RENS Technology, Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), announced today that it will launch its longevity business with the introduction of its Physician Muscle Health Formula® at the 27th World Congress on Anti-Aging Medicine (https://www.a4m.com/las-vegas-december-2019.html) in Las Vegas, Nevada from December 13-15, 2019; MYOS will be in Booth #2090.

December 10, 2019
·
5 min read
Deals

Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillation

Correvio Pharma Corp. announced that NASDAQ and the Toronto Stock Exchange have halted trading of the Company’s common stock.

December 10, 2019
·
8 min read
Job Trends

Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/FT.

December 10, 2019
·
2 min read
Business

Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis

Ontera, Inc., and QuantuMDx Group Limited have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection. T

December 10, 2019
·
3 min read
Drug Development

Dyve Biosciences Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for Treatment of Acute Gout Pain

Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a Phase 2 trial of DYV-700, the company’s topically administered therapeutic being developed to reduce the pain and duration of an acute gout flare.

December 10, 2019
·
3 min read
Business

Introducing the New AlloAid BioNail Implant

In2Bones Global, Inc. announced the global launch of the AlloAid BioNail™, an engineered, sterile allograft implant designed to provide rigid, stable fixation during reconstructive surgery of the hand and foot.

December 10, 2019
·
4 min read
Genetown

Perceptive Advisors Closes Inaugural $210 Million Perceptive Xontogeny Venture Fund to Support Early-Stage Biotech Startups

Perceptive Advisors, an investment management firm focused in life sciences, today announced the closing of its inaugural venture capital fund, the Perceptive Xontogeny Venture Fund, LP (the “PXV Fund”), solely focused on investment in early-stage life science companies.

December 10, 2019
·
4 min read
Genetown

Quellis Biosciences Inc. Announces $17 Million Series A Financing

Quellis Biosciences Inc., an emerging biopharmaceutical company focused on discovering best-in-class new molecules to treat serious rare diseases, today announced its emergence from stealth operations and that it has closed a $17 million Series A financing led by the Perceptive Xontogeny Venture Fund (PXV Fund).

December 10, 2019
·
3 min read
Biotech Beach

Nihon Kohden Launches Life Scope® SVM-7200 Series Vital Sign Monitor, a Portable, Easy-to-Use Monitor with Customizable Early Warning Scoring

Nihon Kohden announced the launch of its Life Scope® SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored.

December 10, 2019
·
4 min read
Pharm Country

Crossix Continues to Expand Health Data Network

Reinforces commitment to building the largest privacy-safe connected patient data network for life sciences

December 10, 2019
·
3 min read